Literature DB >> 26518304

[S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

T Bschleipfer1, T Bach2, R Berges3, K Dreikorn4, C Gratzke5, S Madersbacher6, M-S Michel7, R Muschter8, M Oelke9, O Reich10, C Tschuschke11, K Höfner12.   

Abstract

This report summarizes the relevant aspects of the S2e guideline of the German Urologists for the instrumental treatment of the lower urinary tract symptoms due to benign prostatic hyperplasia. Recommendations are given regarding open and transurethral procedures (TUR-P, bipolar TUR-P, TUI-P, HE-TUMT, TUNA, and the different Laser techniques). Recommendations are also given concerning intraprostatic stents and injection therapies. The influence of the different therapeutic options on bladder outlet obstruction (BOO) is described in detail.

Entities:  

Keywords:  High energy microwave thermotherapy; Injection therapy; Laser techniques; Prostatectomy, open; Transurethral resection

Mesh：

Year:  2016        PMID： 26518304     DOI： 10.1007/s00120-015-3983-0

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  147 in total

1.  A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention.

Authors:  Ibrahim Fathi Ghalayini; Mohammed A Al-Ghazo; Robert S Pickard
Journal:  BJU Int       Date:  2005-07       Impact factor: 5.588

2.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.

Authors:  Carlos Capitán; Cristina Blázquez; M Dolores Martin; Virginia Hernández; Enrique de la Peña; Carlos Llorente
Journal:  Eur Urol       Date:  2011-06-01       Impact factor: 20.096

3.  Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up.

Authors:  P J Gilling; K M Kennett; M R Fraundorfer
Journal:  J Endourol       Date:  2000-11       Impact factor: 2.942

4.  High-energy microwave thermotherapy in the treatment of benign prostatic hyperplasia.

Authors:  L Cavarretta; E Scremin; G Cucciarrè; M Todeschini; G Novella; A Tasca
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

5.  Management of benign prostatic hyperplasia in high risk patients: long-term experience with the Memotherm stent.

Authors:  A Gesenberg; R Sintermann
Journal:  J Urol       Date:  1998-07       Impact factor: 7.450

6.  Transurethral incision versus transurethral resection of the prostate. A subjective and objective analysis.

Authors:  P F Soonawalla; D S Pardanani
Journal:  Br J Urol       Date:  1992-08

7.  The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up.

Authors:  Michael Seitz; Ronald Sroka; Christian Gratzke; Boris Schlenker; Verena Steinbrecher; Wael Khoder; Derya Tilki; Alexander Bachmann; Christian Stief; Oliver Reich
Journal:  Eur Urol       Date:  2007-06-26       Impact factor: 20.096

8.  Laser prostatectomy: initial experience and urodynamic follow-up.

Authors:  J M Cummings; R O Parra; J A Boullier
Journal:  Urology       Date:  1995-03       Impact factor: 2.649

9.  The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.

Authors:  J E Oesterling; S A Kaplan; H B Epstein; A J Defalco; P K Reddy; M B Chancellor
Journal:  Urology       Date:  1994-09       Impact factor: 2.649

Review 10.  Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials.

Authors:  Tania Lourenco; Robert Pickard; Luke Vale; Adrian Grant; Cynthia Fraser; Graeme MacLennan; James N'Dow
Journal:  BMJ       Date:  2008-10-09
View more
  1 in total

1.  [Pharmacological treatment of benign prostatic hyperplasia].

Authors:  M Oelke; E Martinelli
Journal:  Urologe A       Date:  2016-01       Impact factor: 0.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.